» Articles » PMID: 11117527

Activation of Peroxisome Proliferator-activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators

Overview
Journal Mol Endocrinol
Date 2000 Dec 16
PMID 11117527
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear peroxisome proliferator-activated receptors (PPARs) alpha, beta, and gamma activate the transcription of multiple genes involved in lipid metabolism. Several natural and synthetic ligands have been identified for each PPAR isotype but little is known about the phosphorylation state of these receptors. We show here that activators of protein kinase A (PKA) can enhance mouse PPAR activity in the absence and the presence of exogenous ligands in transient transfection experiments. Activation function 1 (AF-1) of PPARs was dispensable for transcriptional enhancement, whereas activation function 2 (AF-2) was required for this effect. We also show that several domains of PPAR can be phosphorylated by PKA in vitro. Moreover, gel retardation experiments suggest that PKA stabilizes binding of the liganded PPAR to DNA. PKA inhibitors decreased not only the kinase-dependent induction of PPARs but also their ligand-dependent induction, suggesting an interaction between both pathways that leads to maximal transcriptional induction by PPARs. Moreover, comparing PPAR alpha knockout (KO) with PPAR alpha WT mice, we show that the expression of the acyl CoA oxidase (ACO) gene can be regulated by PKA-activated PPAR alpha in liver. These data demonstrate that the PKA pathway is an important modulator of PPAR activity, and we propose a model associating this pathway in the control of fatty acid beta-oxidation under conditions of fasting, stress, and exercise.

Citing Articles

PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.

Skoczynska A, Oldakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A Biomolecules. 2024; 14(7).

PMID: 39062500 PMC: 11275227. DOI: 10.3390/biom14070786.


Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting.

Arumugam T, Alli-Shaik A, Liehn E, Selvaraji S, Poh L, Rajeev V Elife. 2023; 12.

PMID: 37769126 PMC: 10538958. DOI: 10.7554/eLife.89214.


Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review.

Borgonovi S, Iametti S, Di Nunzio M Antioxidants (Basel). 2023; 12(6).

PMID: 37372014 PMC: 10295041. DOI: 10.3390/antiox12061283.


The Potential Role of PPARs in the Fetal Origins of Adult Disease.

Guo J, Wu J, He Q, Zhang M, Li H, Liu Y Cells. 2022; 11(21).

PMID: 36359869 PMC: 9653757. DOI: 10.3390/cells11213474.


How trophoblasts fuse: an in-depth look into placental syncytiotrophoblast formation.

Renaud S, Jeyarajah M Cell Mol Life Sci. 2022; 79(8):433.

PMID: 35859055 PMC: 11072895. DOI: 10.1007/s00018-022-04475-z.


References
1.
Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T . Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D.... J Biol Chem. 1990; 265(9):5267-72. View

2.
Issemann I, Green S . Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990; 347(6294):645-50. DOI: 10.1038/347645a0. View

3.
Aronica S, Katzenellenbogen B . Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology. 1991; 128(4):2045-52. DOI: 10.1210/endo-128-4-2045. View

4.
Begum N, Graham A, SUSSMAN K, Draznin B . Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor. Am J Physiol. 1992; 262(2 Pt 1):E142-9. DOI: 10.1152/ajpendo.1992.262.2.E142. View

5.
Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W . Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992; 68(5):879-87. DOI: 10.1016/0092-8674(92)90031-7. View